We did not characterize our tumor samples with respect to genetic alterations that are common in glioblastomas: TERT promoter mutation, EGFR amplification, or gain of chromosome 7 combined with loss of chromosome 10 (2), and so we do not know whether these genetic alterations would influence the inflammatory environment of glioblastoma. The gene discussed is EGFR; the disease is neoplasm.